This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research article
Yazhen Di
Ningbo Women and Children's Hospital
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background
Intravenous immunoglobulin (IVIG) has been widely accepted as a standard treatment against Kawasaki disease (KD). About 20% of patients are nonresponsive after the first IVIG treatment.This study was performed to reveal the responsiveness, mechanism of action, and incidence rate of coronary artery lesions in the long-term follow-up visit of action of IVIG combined with glucocorticoids in the treatment of refractory KD.
Method:
A total of 633 pediatric patients with KD (experimental group) and 200 pediatric patients with upper respiratory infection hospitalized during the same period (control group) were retrospective selected. KD was treated with IVIG combined with aspirin.IVIG-nonresponsive group was given the second treatment.Protocol 1 group was administered 1 g/kg IVIG; Protocol 2 group was administered 2 g/kg IVIG; and Protocol 3 group was administered 1 g/kg IVIG + glucocorticoid (GC). Following the second treatment, the responsive group (Group A) and nonresponsive group (Group B) were classified based on whether the temperature was reduced to normal.
Results
IVIG-nonresponsive group had more coronary artery lesions, longer time of first application of IVIG, and higher WBC count, ESR, CRP, and higher serum levels of Meprin A, IL-1β, IL-6, IL-17A, and IP-10. Protocol 3 group was found with faster abatement of fever, higher response rate, and fewer CALs. The serum levels of Meprin A, IL-1β, and IL-17A in Group B were higher, and the incidence rate of CAL after treatment was up to 78.9% .
Conclusions
The levels of Meprin A, IL-17A, and IL-1β may serve as potentially good indexes to predict refractory KD. IVIG combined with GC to treat refractory KD is more advantageous compared with IVIG alone.
Keywords
Coronary artery lesion（CAL), glucocorticoid (GC), intravenous immunoglobulin (IVIG), Kawasaki disease (KD), refractory type
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 02 Jun, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research article
Yazhen Di
Ningbo Women and Children's Hospital
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 02 Jun, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background
Intravenous immunoglobulin (IVIG) has been widely accepted as a standard treatment against Kawasaki disease (KD). About 20% of patients are nonresponsive after the first IVIG treatment.This study was performed to reveal the responsiveness, mechanism of action, and incidence rate of coronary artery lesions in the long-term follow-up visit of action of IVIG combined with glucocorticoids in the treatment of refractory KD.
Method:
A total of 633 pediatric patients with KD (experimental group) and 200 pediatric patients with upper respiratory infection hospitalized during the same period (control group) were retrospective selected. KD was treated with IVIG combined with aspirin.IVIG-nonresponsive group was given the second treatment.Protocol 1 group was administered 1 g/kg IVIG; Protocol 2 group was administered 2 g/kg IVIG; and Protocol 3 group was administered 1 g/kg IVIG + glucocorticoid (GC). Following the second treatment, the responsive group (Group A) and nonresponsive group (Group B) were classified based on whether the temperature was reduced to normal.
Results
IVIG-nonresponsive group had more coronary artery lesions, longer time of first application of IVIG, and higher WBC count, ESR, CRP, and higher serum levels of Meprin A, IL-1β, IL-6, IL-17A, and IP-10. Protocol 3 group was found with faster abatement of fever, higher response rate, and fewer CALs. The serum levels of Meprin A, IL-1β, and IL-17A in Group B were higher, and the incidence rate of CAL after treatment was up to 78.9% .
Conclusions
The levels of Meprin A, IL-17A, and IL-1β may serve as potentially good indexes to predict refractory KD. IVIG combined with GC to treat refractory KD is more advantageous compared with IVIG alone.
Loading...